A long-acting HIV prevention injection, which protects recipients for six months per dose, has been administered to almost 55,000 people in South Africa, according to the health department. The Sowetan profiles four individuals who received the jab, highlighting their experiences with the new prevention method. The rollout marks a significant step in the country's efforts to reduce new HIV infections through expanded access to preventive treatment.

Four South Africans from groups the government aims to reach with the six-monthly HIV prevention injection lenacapavir have shared their experiences, according to TimesLIVE. They explained why they chose the long-acting shot, described what happened during their clinic visits, and said whether they plan to return for another dose. The accounts offer insight into the rollout of the twice-yearly injection as part of South Africa's HIV prevention efforts.

The GP Health Department reported that the rollout of Lenacapavir, an HIV prevention drug, exceeded its targets in the first month of implementation. This development indicates a positive response to the drug's introduction in the region.

The Ministry of Health announced that demand for Lenacapavir, a new HIV prevention injection launched in April, is currently exceeding the available supply, particularly among men seeking the twice-yearly treatment. Dr. Herbert Kadama, who coordinates Pre-Exposure Prophylaxis (PrEP) at the Ministry, spoke at a meeting with HIV advocates, researchers, and policymakers about the situation.

The rollout of lenacapavir (LEN) in Gauteng has faced challenges, with patients in parts of Pretoria being turned away due to delays. It has been two weeks since the initiation of the vaccination program, but access remains limited for some individuals, according to Health-e News.

Health educators and HIV/AIDS focal persons in the Karamoja sub-region are receiving training on the implementation of Lenacapavir, a new injectable drug for HIV prevention introduced by the Ministry of Health. This training, organized by the Uganda AIDS Commission in Moroto District, aims to equip health communication officers and focal persons with the necessary skills for the rollout of this six-month HIV prevention jab.